Streetbeat News

Equity Actions

ALT

Altimmune (NYSE:ALT) has seen a 12.87% increase in short interest since its last report, with 10.66 million shares sold short, representing 20.0% of its float. The short interest ratio is 1.18 days. High short interest can indicate bearish market sentiment but doesn't necessarily predict a price drop. Altimmune's short interest is higher than its peer group average of 12.28%.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 5:45 pm

ABT

Abbott Laboratories (NYSE:ABT) has seen a decrease in short interest by 11.59% since the last report, with 10.55 million shares sold short, representing 0.61% of available shares. The average time to cover these short positions is 2.3 days. A decrease in short interest can indicate a more bullish sentiment towards the stock. Compared to its peers, Abbott Laboratories has a lower short interest as a percentage of float, with the peer group average at 3.56%.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 5:45 pm

AMC

AMC Entertainment Holdings (NYSE:AMC) has seen a 3.51% increase in short interest since its last report, with 24.10 million shares sold short, representing 9.74% of its float. The short interest is higher than the peer group average of 8.28%. While an increase in short interest can indicate bearish sentiment, it does not necessarily predict a price drop. It takes traders approximately 1.35 days to cover their short positions based on current trading volume.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 5:45 pm

APPF

AXP

CRBP

EHTH

INTC

PCSA

TKLF

American Express (NYSE:AXP) shares rose over 7% after reporting Q4 financial results and announcing plans to increase its dividend, despite missing revenue and EPS consensus. AppFolio (NASDAQ:APPF) shares surged 28% on strong Q4 results and guidance. Corbus Pharmaceuticals (NASDAQ:CRBP) soared 221% on positive clinical study data. eHealth (NASDAQ:EHTH) gained 24% on preliminary Q4 results. Intel (NASDAQ:INTC) fell 10% due to a weak Q1 forecast. Processa Pharmaceuticals (NASDAQ:PCSA) dropped 25% after announcing a public offering. Yoshitsu (NASDAQ:TKLF) plummeted 60% after a direct offering and private placement announcement. Crude oil was down 1%, while U.S. stocks traded higher overall.

Portfolio Pulse from Avi Kapoor

January 26, 2024 | 5:00 pm

PCSA

Processa Pharmaceuticals Inc (NASDAQ:PCSA) saw its shares surge 148.8% to close at $5.10 on Thursday. The company announced a public offering of 1.56 million shares and warrants at $4.50, aiming to raise $7.0 million. Following the offering, the stock traded lower on high volume. Processa also completed a Phase 1b trial for NGC-Cap, selecting two dosage regimens for a Phase 2 trial in advanced breast cancer. On Monday, the stock began trading on a reverse split basis of 1-for-20, and on Friday, shares dropped 23.9% to $3.88 in premarket trading.

Portfolio Pulse from Vandana Singh

January 26, 2024 | 4:16 pm

EFSH

Shares of 1847 Holdings LLC (AMEX:EFSH) are rising after the company announced securing a $750,000 credit facility for its subsidiary Wolo Manufacturing Corp. The credit facility is expected to strengthen Wolo's liquidity and financial flexibility, allowing for potential sales growth of 50-70% in 2024 without equity dilution. This news follows a recent 1-for-4 reverse stock split effective January 8, 2024. EFSH's stock had dropped over 23% in the past month but is currently up 5.35% at $1.591.

Portfolio Pulse from Lekha Gupta

January 26, 2024 | 4:12 pm

PYPL

The article provides an industry comparison of PayPal Holdings (NASDAQ:PYPL) against its competitors in the Financial Services industry. It highlights PayPal's financial metrics such as P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth, comparing them to industry averages and top peers. PayPal shows favorable growth potential with a lower P/E ratio than the industry average, potential undervaluation with a lower P/B ratio, and strong profitability with higher EBITDA and gross profit. However, it has a lower ROE and revenue growth compared to the industry, suggesting inefficiencies and limited expansion opportunities.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 4:02 pm

IBM

IBM (NYSE:IBM) is analyzed in comparison to its IT Services industry competitors, revealing its strong market positioning and growth potential. Key financial metrics such as P/E, P/B, P/S, ROE, EBITDA, gross profit, and revenue growth are examined, with IBM showing favorable growth potential, possible undervaluation, efficient equity use, robust profitability, and market outperformance. IBM's debt-to-equity ratio suggests a balanced financial structure.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 4:01 pm

INTC

A financial analysis comparing Intel (NASDAQ:INTC) to its competitors in the Semiconductors & Semiconductor Equipment industry reveals that Intel's PE, PB, and PS ratios are below industry averages, suggesting potential undervaluation. However, Intel's ROE, EBITDA, and revenue growth are lower than its peers, indicating possible profitability and growth challenges. Intel's gross profit is higher than the industry average, reflecting strong profitability from core operations. The company also has a lower debt-to-equity ratio, indicating a stronger financial position with less reliance on debt.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 4:01 pm

MTZ

MasTec (NYSE:MTZ) has been reviewed by 8 analysts in the last three months, with a mix of bullish and bearish sentiments. The average 12-month price target is $69.75, with a high of $92.00 and a low of $54.00, marking a 15.35% decrease from the previous average. Analysts from Citigroup, Baird, Keybanc, Stifel, Goldman Sachs, and Barclays have updated their ratings and price targets, reflecting their latest views on the company's performance. MasTec operates in North America, focusing on infrastructure construction in various industries. Despite solid revenue growth, the company's net margin and ROE are below industry averages, and it has a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 4:00 pm